(PharmaNewsWire.Com, January 05, 2017 ) Report SummaryCancer is a group of diseases characterized by abnormal cell growth. It is a multi-step process, as a single mutation is almost certainly insufficient to cause a cell to become malignant. A number of cellular processes must be deregulated to allow...
(PharmaNewsWire.Com, January 06, 2017 ) Branded generics are the drugs which are biosimilars to the innovator products and marketed under different brand names. In other words, branded generics, sometimes also called as ‘value-added generics’ can either be a novel dosage form of an original patented...
(PharmaNewsWire.Com, January 06, 2017 ) Halal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmaceuticals refer to medicines that should not contain any parts of animals (dogs, pigs and ones particularly with pointed teeth), insects (bees),...
(PharmaNewsWire.Com, January 06, 2017 ) Dermal filler is the non-invasive treatment for facial rejuvenation and are used to as anti-ageing agents. As people age, facial skin begins to lose its flexibility and natural hydration that helps support, shape and add volume to the face. This leads to wrinkles...
(PharmaNewsWire.Com, January 06, 2017 ) Market OverviewThe rising incidence rate of hearing disorders among the geriatric population has resulted in growing sales of efficient hearing devices. The hearing disabilities among war veterans as well as new-born infants is one of the biggest concerns...
(PharmaNewsWire.Com, January 05, 2017 ) DelveInsight's, " Indolent Lymphoma-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Indolent Lymphoma. The DelveInsight'sReport covers the product profiles in various stages of development...
(PharmaNewsWire.Com, January 05, 2017 ) DelveInsight's, "Tumor Necrosis Factor Alpha (TNF-a) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Tumor Necrosis Factor Alpha (TNF-a) Agonists. The DelveInsight's Report...
(PharmaNewsWire.Com, January 05, 2017 ) DelveInsight's Report, "Gastric Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key...
(PharmaNewsWire.Com, January 05, 2017 ) Publisher's, "11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1)...
(PharmaNewsWire.Com, January 05, 2017 ) Publisher's, "5-HT4 Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the 5-HT4 Agonists. The Publisher's Report covers the product profiles in various stages of development including...
(PharmaNewsWire.Com, January 05, 2017 ) Publisher's, "5-HT1A Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the 5-HT1A Antagonists. The Publisher's Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, January 05, 2017 ) Publisher's, "4-1BB (CD137) Agonist-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the 4-1BB (CD137) Agonist. The Publisher's Report covers the product profiles in various stages of...
(PharmaNewsWire.Com, January 05, 2017 ) According to Publisher, the Global Continuous Renal Replacement Therapy (CRRT) Market is accounted for $0.78 billion in 2015 and is expected to reach $1.26 billion by 2022 growing at a CAGR of 7.1%. The clinical advantages of CRRT Techniques are the primary...
(PharmaNewsWire.Com, January 05, 2017 ) According to Publisher, the Global Biodetectors and Accessories Market is expected to reach $15.2 billion by 2022. Continuous decline of environmental surroundings as a result of rising pollution and growing demand for technologically highly developed instruments...
(PharmaNewsWire.Com, January 05, 2017 ) According to Publisher, the Global Bariatric Surgery Devices Market is accounted for $1.35 billion in 2015 and is expected to reach $2.96 billion by 2022 growing at a CAGR of 11.9%. Huge technological advancements in obesity healthcare is creating a buzz among...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: